Merck considering purchase of cancer drug maker Seagen - WSJ
Go back to Merck considering purchase of cancer drug maker Seagen - WSJ| Merck & Co. (NYSE: MRK) | Delayed: 148.17 +0.19 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.98 | 52 Week High | $65.46 | |||
| Open | $148.06 | 52 Week Low | $47.97 | |||
| Day High | $149.98 | P/E | 100.80 | |||
| Day Low | $147.67 | EPS | $1.47 | |||
| Volume | 967,576 | |||||
| Seattle Genetics Inc /wa (NASDAQ: SGEN) | Delayed: 228.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.74 | 52 Week High | $75.36 | |||
| Open | $22.94 | 52 Week Low | $26.02 | |||
| Day High | $228.74 | P/E | N/A | |||
| Day Low | $228.74 | EPS | $-0.51 | |||
| Volume | 759,302 | |||||
